ClinConnect ClinConnect Logo
Search / Trial NCT06020469

Comparative Effects of Ciprofol and Propofol on Pain Intensity on the First Day After Surgery: a Retrospective, Propensity Score Matched, Cohort Study

Launched by GUANGDONG SECOND PROVINCIAL GENERAL HOSPITAL · Aug 28, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Data Platform Machine Learning Postoperative Acute Pain

ClinConnect Summary

This clinical trial is studying how two different medications, Ciprofol and Propofol, affect pain levels in patients on the first day after surgery. The researchers want to find out which medication helps to reduce pain better for patients who have undergone surgery with general anesthesia. They are currently looking for participants who are at least 18 years old and will be having non-local anesthesia surgery. However, individuals with incomplete health information, those who have had multiple surgeries, or who need to go to intensive care after surgery will not be eligible to participate.

If you decide to join the study, you'll be contributing to important research that aims to improve pain management after surgery. The trial is still recruiting participants, and it welcomes individuals of all genders and a wide age range. By participating, you may help doctors better understand how to manage pain for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients were included if they were above 18 years old, undergoing non-local anesthesia surgery.
  • Exclusion Criteria:
  • The basic information such gender, age, height, weight, and body mass index (BMI) were missing.
  • Patients undergoing day surgery, with a history of multiple operations, or entering ICU after surgery, and losing the NRS score during movement at 24h after surgery.

About Guangdong Second Provincial General Hospital

Guangdong Second Provincial General Hospital is a leading medical institution in Guangdong Province, China, renowned for its commitment to advanced healthcare and clinical research. As a prominent clinical trial sponsor, the hospital emphasizes innovative therapeutic solutions and evidence-based practices, aiming to enhance patient outcomes through rigorous scientific investigation. With a multidisciplinary team of experienced clinicians and researchers, the hospital fosters a collaborative environment that promotes the development of novel treatments across various medical fields, ensuring adherence to the highest standards of safety and ethics in clinical trials.

Locations

Guangzhou, Guangdong, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported